TARGET: A Study to Evaluate the Treatment of Patients With Acute Decompensated Heart Failure (ADHF) Using an Automated Fluid Management System
Not Applicable
- Conditions
- Congestive Heart Failure
- Interventions
- Device: Reprieve Cardiovascular System
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- CardioRenal Systems, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03897842
- Locations
- 🇵🇱
Military Hospital of Wroclaw, Wroclaw, Poland
Reprieve ADHF EFS IDE
Not Applicable
- Conditions
- Congestive Heart Failure
- Interventions
- Device: Reprieve Cardiovascular System
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- CardioRenal Systems, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03866551
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
Phase 3
Active, not recruiting
- Conditions
- Contrast Induced Nephropathy
- Interventions
- Device: RenalGuard TherapyDrug: Standard Therapy
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- CardioRenal Systems, Inc.
- Target Recruit Count
- 326
- Registration Number
- NCT01456013
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸University of Massachusetts, Worcester, Massachusetts, United States
🇺🇸Clearwater Cardiovascular, Clearwater, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath